Step 1 Reproductive

Reproductive covers embryology, anatomy, physiology, obstetrics, gynecology, male urology, STIs, and pharmacology — roughly 10–15% of USMLE Step 1. Embryology questions tend to be standalone or short vignettes asking you to predict a phenotype given a specific hormone or gene defect. Pathology questions are heavily integrated into clinical scenarios: a woman with pelvic pain, a pregnant patient with bleeding, a man with a scrotal mass. For anyone reviewing high-yield reproductive and OB/GYN topics for Step 1, sexual differentiation disorders and obstetric emergencies are the two clusters that generate the most questions.

The tricky part is that reproductive physiology underpins almost everything else. If you do not know what MIS and testosterone each do in fetal development, CAIS and 5-alpha-reductase deficiency are just memorization without logic. Students consistently confuse testosterone and DHT roles — testosterone virilizes the internal Wolffian ducts, while DHT shapes the external genitalia, so a 5-alpha-reductase deficiency produces female-appearing external genitalia despite normal internal male structures. Build the physiology first, then the pathology makes sense.

Obstetric emergencies — preeclampsia, abruption, ectopic, PPH — are high-yield and heavily tested because management decisions are time-sensitive and testable on USMLE Step 1. Another common misconception: students think magnesium sulfate in preeclampsia lowers blood pressure, when its role is purely seizure prevention. STIs are tested both on organism-level facts and on clinical discrimination (painful vs painless ulcer, discharge type, partner treatment). Step 1 reproductive pharmacology questions often hinge on one key contraindication or mechanism nuance — the nitrate interaction with PDE5 inhibitors, finasteride halving PSA, tamoxifen's tissue-specific agonism.